COVID-19 outcomes in persons with multiple sclerosis treated with rituximab
Volume: 57, Pages: 103371 - 103371
Published: Jan 1, 2022
Abstract
Outcomes of COVID-19 in PwMS (persons with Multiple Sclerosis) on immunosuppressive therapies, particularly B-cell depletors, can be unpredictable. There has been a concern for postponing or avoiding use of Rituximab (RTX) during the COVID-19 pandemic. We report the course and outcomes of COVID-19 in PwMS receiving RTX.PwMS receiving RTX who contracted COVID-19 were closely monitored by tele-consultation and/or evaluated during hospital visits....
Paper Details
Title
COVID-19 outcomes in persons with multiple sclerosis treated with rituximab
Published Date
Jan 1, 2022
Volume
57
Pages
103371 - 103371
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History